CardioGenics Holdings (CardioGenics Holdings) Total Stockholders Equity : $-1.79 Mil (As of Jan. 2016)

View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Total Stockholders Equity?

CardioGenics Holdings's Total Stockholders Equity for the quarter that ended in Jan. 2016 was $-1.79 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. CardioGenics Holdings's Book Value per Share for the quarter that ended in Jan. 2016 was $-0.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. CardioGenics Holdings's Debt-to-Equity for the quarter that ended in Jan. 2016 was -0.21.

CardioGenics Holdings Total Stockholders Equity Historical Data

The historical data trend for CardioGenics Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Total Stockholders Equity Chart

CardioGenics Holdings Annual Data

Trend

Jul06

Jul07

Jul08

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Oct15

Total Stockholders Equity

Get a 7-Day Free Trial

0.87

-0.17

-0.56

-1.16

-1.56

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
Total Stockholders Equity	Get a 7-Day Free Trial															-1.55	-1.32	-1.63	-1.56	-1.79

CardioGenics Holdings (OTCPK:CGNH) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

CardioGenics Holdings's Book Value per Share for the quarter that ended in Jan. 2016 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-1.787	-	0)	/	92.8667
	=	-0.02

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

CardioGenics Holdings's Debt-to-Equity for the quarter that ended in Jan. 2016 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.378	+	0)	/	-1.787
	=	-0.21

CardioGenics Holdings Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8

Website

http://www.cardiogenics.com

CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines